The role of celecoxib in glioblastoma treatment: a review of literature
Objective: Glioblastoma (GB) is the most aggressive and lethal type of brain tumor. Despite the standard treatments and improvements, the overall survival (OS) and progression free survival (PFS) are not optimal. Celecoxib (CEL) has been considered as one of the adjuvant agents in patients with GB d...
Main Authors: | F. Tavakolian, S. Sana Khezrnia, M. Dehghani, A. Mansouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2020-07-01
|
Series: | World Cancer Research Journal |
Subjects: | |
Online Access: | https://www.wcrj.net/wp-content/uploads/sites/5/2020/11/e1617.pdf |
Similar Items
-
Cerebellar glioblastoma multiforme in an adult
by: João Paulo Mattos, et al.
Published: (2006-03-01) -
Developing a Radiomics Signature for Supratentorial Extra-Ventricular Ependymoma Using Multimodal MR Imaging
by: Apoorva Safai, et al.
Published: (2021-07-01) -
Role of extent of resection on the survival of glioblastoma multiforme
by: Dipak Chaulagain, et al.
Published: (2023-06-01) -
Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience
by: Shaakir eHasan, et al.
Published: (2015-05-01) -
Primary spinal glioblastoma multiforme. Single center experience and literature review
by: Milos Jokovic, et al.
Published: (2021-06-01)